Yumanity Therapeutics Company
Yumanity Therapeutics is a biotechnology company that transforms drug discovery for diseases caused by protein misfolding.
Technology:
Cancer
Industry:
NeuroTech
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2014-01-01
Employees Number:
11-50
Funding Status:
IPO
Total Funding:
137361779
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership